The historic rise of Viagra has firmly established as a benchmark of pharmaceutical success, but its future within the broader industry now presents questions about future yields . Alternative versions are eroding exclusivity , prompting anxieties that investing in companies closely tied to Viagra's previous standing could be a speculative decis… Read More